Jieqing Li

1.3k citations
45 papers · 955 indexed · h-index 15
Topics
Breast Cancer Treatment Studies (13 papers)Cancer Treatment and Pharmacology (7 papers)Advanced Breast Cancer Therapies (6 papers)

In The Last Decade

Jieqing Li

42 papers receiving 933 citations

Peers

Jieqing Li
Comparison fields: 5 of 108
  • Pharmacology 308
  • Molecular Biology 285
  • Cancer Research 201
  • Oncology 194
  • Plant Science 166
Replace Youn Kyung Choi with:
Youn Kyung Choi South Korea
Paola De Cicco Italy
Xiqing Bian Macao
Hong‐Zin Lee Taiwan
Hyun Hwangbo South Korea
Jarosław Paluszczak Poland
Ana Calcagnotto United States
Bum‐Sang Shim South Korea
Yue Lu China
Jieqing Li relative to Youn Kyung Choi South Korea Youn Kyung Choi's profile →
Citations per field
00.5×1.5×2.0×
Youn Kyung Choi · 1×
Citations per year

Countries citing papers authored by Jieqing Li

Since Specialization
Citations

This map shows the geographic impact of Jieqing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieqing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieqing Li more than expected).

Fields of papers citing papers by Jieqing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jieqing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieqing Li. The network helps show where Jieqing Li may publish in the future.

Co-authorship network of co-authors of Jieqing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jieqing Li. A scholar is included among the top collaborators of Jieqing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jieqing Li. Jieqing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 6
5 4
6 7
7 2
8 1
9 5
10 5
11 37
12 7
13 8
14 15
15 67
16
[Study on the Discrimination of Boletus Edulis from Different Years and Origins with FTIR].
2
17
ICP-AES Determination of Mineral Content in Boletus tomentipes Collected from Different Sites of China.
5
18 72
19 324
20 1

About Jieqing Li

Jieqing Li is a scholar working on Cancer Research, Oncology and Dermatology, having authored 45 papers that have together received 955 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (7 papers) and Advanced Breast Cancer Therapies (6 papers). The work is most often cited by research in Pharmacology (308 citations), Biochemistry (84 citations) and Cancer Research (201 citations). Jieqing Li has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Yuanzhong Wang, Honggao Liu, Yanli Zhao, Tao Li, Ji Zhang, Xuemei Wang, Wei Cao, Jaydutt V. Vadgama, Qiongyu Hao and Yong Wu. Their work appears in journals such as Journal of Clinical Oncology, Food Chemistry and Science Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026